Stephen Hoge, President at Moderna, Inc. (MRNA), sold 254 shares at $84.10 ($21K) on 2024-08-12, disclosed to the SEC on 2024-08-13.
Seasonal sale ($21k) by President — this insider has traded MRNA in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| MRNA | SELL | 2026-06-17 | $2.7M | — | Filing → |
| MRNA | SELL | 2026-05-18 | $2.6M | — | Filing → |
| MRNA | SELL | 2026-02-25 | $7.8M | — | Filing → |